Files
statdx/docs_md/articles/myelin-oligodendrocyte-glycoprotein-antibody-associated-disease-brain_a5b155b3-03ee-4934-8023-e681ed9e8296.md
Ross 1e36a4957c .
2025-10-20 08:40:33 +01:00

34 KiB

title, docid, authors, breadcrumbs, category, cmeTopicId, documentVersionId, imageCount, lastUpdated, pageDescription, pageKeywords, pageTitle, enhancedTitle, type, references, breadcrumbs
title docid authors breadcrumbs category cmeTopicId documentVersionId imageCount lastUpdated pageDescription pageKeywords pageTitle enhancedTitle type references breadcrumbs
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Brain a5b155b3-03ee-4934-8023-e681ed9e8296
key value
99e1aff7-f42c-43a0-95ae-d89c8551aa01 Kevin R. Moore, MD
name slug treeNodeId
Pediatrics pediatrics a915965c-d436-44cf-ae65-2f22e7246ea4
name slug treeNodeId
Diagnosis diagnosis 2b5cea64-a083-489e-ac0c-ec14ba059026
name slug treeNodeId
Pediatric Neuroradiology pediatric-neuroradiology d0eb8f4a-e769-43dd-896c-8c9c27ce8759
name slug treeNodeId
Brain brain feaaadba-649b-4f0a-9aad-9188a8f9926a
name slug treeNodeId
Pathology-Based Diagnoses pathology-based-diagnoses 2d26053f-23a7-4062-bf35-a93775ae1209
name slug treeNodeId
Inflammatory and Demyelinating Disease inflammatory-and-demyelinating-dis- cb319228-da96-4d29-8276-c72388a57656
name slug treeNodeId
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Brain myelin-oligodendrocyte-glycoprotei- null
Pediatrics 5358b581-ed5c-44dc-8b93-3d6dcccbe83e 74a3bf99-9d92-4e81-8b98-044d1cee70ba 14 02/07/24 Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Brain Pediatrics, Diagnosis, Pediatric Neuroradiology, Brain, Pathology-Based Diagnoses, Inflammatory and Demyelinating Disease, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Brain Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Brain | STATdx Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Brain DX true
Pediatrics
Diagnosis
Pediatric Neuroradiology
Brain
Pathology-Based Diagnoses
Inflammatory and Demyelinating Disease
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Brain

title: "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Brain" docid: "a5b155b3-03ee-4934-8023-e681ed9e8296" authors:

  • key: "99e1aff7-f42c-43a0-95ae-d89c8551aa01" value: "Kevin R. Moore, MD" breadcrumbs:
  • name: "Pediatrics" slug: "pediatrics" treeNodeId: "a915965c-d436-44cf-ae65-2f22e7246ea4"
  • name: "Diagnosis" slug: "diagnosis" treeNodeId: "2b5cea64-a083-489e-ac0c-ec14ba059026"
  • name: "Pediatric Neuroradiology" slug: "pediatric-neuroradiology" treeNodeId: "d0eb8f4a-e769-43dd-896c-8c9c27ce8759"
  • name: "Brain" slug: "brain" treeNodeId: "feaaadba-649b-4f0a-9aad-9188a8f9926a"
  • name: "Pathology-Based Diagnoses" slug: "pathology-based-diagnoses" treeNodeId: "2d26053f-23a7-4062-bf35-a93775ae1209"
  • name: "Inflammatory and Demyelinating Disease" slug: "inflammatory-and-demyelinating-dis-" treeNodeId: "cb319228-da96-4d29-8276-c72388a57656"
  • name: "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Brain" slug: "myelin-oligodendrocyte-glycoprotei-" treeNodeId: null category: "Pediatrics" cmeTopicId: "5358b581-ed5c-44dc-8b93-3d6dcccbe83e" documentVersionId: "74a3bf99-9d92-4e81-8b98-044d1cee70ba" imageCount: 14 lastUpdated: "02/07/24" pageDescription: "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Brain" pageKeywords: "Pediatrics, Diagnosis, Pediatric Neuroradiology, Brain, Pathology-Based Diagnoses, Inflammatory and Demyelinating Disease, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Brain" pageTitle: "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Brain | STATdx" enhancedTitle: "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Brain" type: "DX" references: true breadcrumbs:
  • "Pediatrics"
  • "Diagnosis"
  • "Pediatric Neuroradiology"
  • "Brain"
  • "Pathology-Based Diagnoses"
  • "Inflammatory and Demyelinating Disease"
  • "Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Brain"

KEY FACTS

  • Terminology

    • Myelin oligodendrocyte glycoprotein (MOG), MOG antibody-associated disease (MOGAD)
  • Imaging

    • Orbits - Abnormal bilateral long-segment hyperintensity of optic nerve anterior segments - Usually spares optic chiasm, retrochiasmatic pathways
    • Brain - T2-hyperintense, fluffy, poorly demarcated lesions - Bilateral, large brainstem and deep gray nuclei lesions more common in children
  • Top Differential Diagnoses

    • Multiple sclerosis
    • Acute disseminated encephalomyelitis (ADEM)
    • Neuromyelitis optica spectrum disorder (NMOSD)
    • Brain neoplasms
    • Collagen vascular disorders
    • Hemophagocytic lymphohistiocytosis (HLH)
    • Mitochondrial diseases
    • Leukodystrophies
  • Pathology

    • MOG protein expressed on surface of oligodendrocytes, in myelin sheath
    • Cortical demyelination common, topographically adjacent meningeal inflammation
  • Clinical Issues

    • Unilateral or bilateral optic neuritis (ON)
    • Most common - Acute disseminated encephalomyelitis-like presentation with altered mental status, focal neurologic deficits - Transverse myelitis
    • Less common: Cerebral cortical encephalitis - Progressive clinical decline with leukodystrophy-like MR pattern
    • Infectious prodrome precedes initial symptom onset ≤ 60% of patients
  • Diagnostic Checklist

    • Best diagnostic clue: Bilateral anterior ON + longitudinally extensive transverse myelitis (LETM)
    • Evaluate optic nerves on brain imaging to identify concurrent ON
    • Ovoid periventricular (Dawson fingers) lesions nottypical of MOGAD

TERMINOLOGY

  • Abbreviations

    • Myelin oligodendrocyte glycoprotein (MOG), MOG antibody-associated disease (MOGAD)
  • Definitions

    • Inflammatory process of CNS characterized by attacks of immune-mediated demyelination
    • Clinically and laboratory distinguishable from multiple sclerosis (MS) and AQP4-IgG (+) neuromyelitis optica spectrum disorder (NMOSD)

IMAGING

  • General Features

    • Best diagnostic clue

      - Bilateral **anterior** optic pathway neuritis + longitudinally extensive transverse myelitis (**LETM**)
              - Bilateral involvement during 1st optic neuritis (ON) presentation in 84% of MOGAD patients
      - Brain imaging findings dependent on age at diagnosis (adult vs. child)
      
    • Location

      - Orbits, cerebral hemispheres, spinal cord
      - Cortical gray matter (GM)/paracortical white matter (WM) most common location for MOGAD lesions
      
    • Size

      - Variable
      
  • CT Findings

    • NECT

      - Hypodense lesions in areas of acute demyelination
      
    • CECT

      - Variable enhancement pattern, similar to MR
      
  • MR Findings

    • T1WI

      - ± hypointensity within brain lesions
      - Not typical of "black holes" seen with MS
      
    • T2WI

      - Orbits
              - Abnormal bilateral long-segment hyperintensity of optic nerve **anterior** segments
                        - Best seen on fat-saturated imaging
                        - Usually spares optic chiasm, retrochiasmatic pathways
              - Edematous, enlarged, tortuous optic nerve or nerves
              - ± optic nerve head elevation
      - Brain
              - Hyperintensity in cortical GM, subcortical WM, deep WM, and deep GM
                        - Perivenous confluent pattern around small veins, lacking radiologic central vein sign (as opposed to MS)
              - Bilateral hyperintense, fluffy, poorly demarcated lesions
                        - Brain lesions present at onset < 1/2 of adults, more common in children
                        - 1/3 infratentorial, predominantly in brainstem and cerebellar peduncles (children)
                        - Ovoid periventricular (Dawson fingers) lesions **not** typical
              - Bilateral, large brainstem and deep gray nuclei lesions more common in children
      
    • STIR

      - Orbits
              - Abnormal bilateral long-segment hyperintensity of anterior optic nerve segments 
                        - Spares optic chiasm, retrochiasmatic pathways
                        - ± optic nerve head elevation
      - Brain
              - Same as FLAIR
      
    • FLAIR

      - Orbits
              - Same as STIR
      - Brain
              - Same as T2WI, lesions usually better seen
              - ± T2-hypointense subcortical WM lesions
              - Unilateral cortical **FLA**IR-hyperintense lesions in anti-**M**OG-associated encephalitis with **s**eizures (**FLAMES**)
      
    • T1WI C+

      - Orbits
              - Avid optic nerve enhancement
              - Perioptic nerve sheath and surrounding orbital fat enhancement
                        - In 50-80% of MOGAD patients
      - Brain
              - Variable; absent, faint, or patchy
              - Enhancement in ≈ 12% of lesions
              - ± leptomeningeal enhancement, ± adjacent cortical lesions
      
  • Imaging Recommendations

    • Protocol advice

      - MR ± contrast of orbits, brain, and spinal cord
      

DIFFERENTIAL DIAGNOSIS

  • Multiple Sclerosis

    • Optic nerves: Typically unilateral, short-segment, less extensive enhancement than MOGAD, NMOSD - ± restricted diffusion - Bilateral ON during initial presentation ≈ 23% of patients with MS-associated ON
    • Brain: Presence of perpendicular periventricular lesions (Dawson fingers), "black holes"
    • (+) CSF oligoclonal bands, (-) MOG antibodies, (-) AQP4 antibodies
  • Acute Disseminated Encephalomyelitis

    • Polyfocal neurologic deficits and encephalopathy not explainable by fever
    • Diffuse T2 signal abnormality in cortical GM, subcortical WM, deep WM, deep GM (or combination)
    • ± linear, patchy, nodular enhancement
    • May clinically mimic NMOSD and MOGAD - Clinical presentation similar to NMOSD, but AQP4 IgG (-) - Prolonged MOGAD IgG positivity suggests MOGAD
  • Neuromyelitis Optica Spectrum Disorder

    • Most patients (+) for AQP4-IgG antibodies (seropositive NMOSD)
    • Preceding infectious prodrome in ≈ 10% patients
    • Optic nerves: Favors posterior optic pathway segments (optic chiasm, retrochiasmatic optic tract) - Bilateral involvement during 1st ON presentation in 82% of patients with AQP4-IgG (+) NMOSD
    • Brain: Medulla oblongata (45.5%) and area postrema (31.8%) lesions most common
  • Brain Neoplasms

    • Intracranial mass lesion - May mimic tumefactive MS on imaging
    • Distinguish on clinical and imaging features
  • Collagen Vascular Disorders

    • Systemic lupus erythematosus, Sjögren syndrome neuro-Behçet disease, neurosarcoidosis
    • Look for elevated markers of systemic inflammation - Abnormal antinuclear antibody profile, (+) double-stranded DNA antibodies, elevated angiotensin converting enzyme, and (+) antiphospholipid antibodies
  • Hemophagocytic Lymphohistiocytosis

    • Primary involvement of CNS (rarely) precedes systemic manifestations of hemophagocytic lymphohistiocytosis (HLH)
    • Pediatric CNS-isolated HLH can mimic acute disseminated encephalomyelitis (ADEM) clinically and on imaging
  • Mitochondrial Diseases

    • Typical MR features include abnormal T2 hyperintensity in basal ganglia or parietooccipital regions
    • (Mitochondrial) myopathy, encephalopathy, lacticacidosis, and stroke-like episodes syndrome (MELAS), Leigh disease, others
    • Elevation of serum and CSF lactate levels
  • Leukodystrophies

    • Metachromatic leukodystrophy (MLD), X-linked adrenoleukodystrophy (ALD), Alexander disease (AD), Krabbe disease (globoid cell leukodystrophy)
    • Look for characteristic imaging or laboratory abnormalities

PATHOLOGY

  • General Features

    • MOG is myelin protein expressed on outer surface of oligodendrocytes and myelin sheath - Function not known; may act as cell adhesion molecule, regulate microtubule stability, and modulate myelin immune interactions
    • Cortical demyelination common, topographically associated with adjacent meningeal inflammation
    • Intracortical > subcortical WM demyelinated lesions predominate (compared to MS)
    • MOG-IgG present in ~ 1/3 of pediatric acute acquired demyelinating syndromes
  • Staging, Grading, & Classification

    • New diagnostic criteria for MOGAD (March 2023) - Intended to improve MOGAD identification, distinguish it from other disorders with overlapping clinical features, such as NMOSD, MS - 3 primary diagnostic criteria - 1 of 6 core clinical demyelinating events [i.e., ON, transverse myelitis (TM), ADEM-like encephalopathy, cerebral monofocal or polyfocal deficits, brainstem or cerebellar deficits, or cerebral cortical encephalitis] - MOG-immunoglobulin G (IgG) antibody test (+) - In absence of serum positivity for MOG-immunoglobulin G (IgG) by cell-based assay, CSF positivity for MOG-IgG fulfills criteria - Exclusion of better diagnosis
  • Microscopic Features

    • Initial peripheral T-cell activation of T cells → reactivation in subarachnoid/perivascular spaces by MOG-laden antigen-presenting cells and inflammatory CSF milieu - T cells, granulocytes cross blood brain barrier, infiltrate CNS parenchyma - Macrophages/microglia appear in lesions
    • Anti-MOG antibodies opsonize MOG, activate complement- and antibody-dependent cellular cytotoxicity
    • CD4 (+) T-cell and granulocytic inflammation typical - CD8 (+) T-cell infiltrate typical in MS
    • Perivenous confluent pattern around small veins - Coexisting perivenous and confluent demyelination + cortical demyelination - Intracortical demyelinating lesions predominate
    • Extensive subpial cortical demyelination with microglial activation, inflammatory infiltrate
    • Affects oligodendrocytes but spares astrocytes (unlike NMOSD) - Oligodendroglial progenitor cells spared because they do not yet express MOG
    • Chronic active lesions absent
  • Laboratory Evaluation

    • Serum MOG-IgG antibody testing by cell-based assay
    • Serum AQP4-IgG testing to exclude NMOSD
    • CSF testing for oligoclonal bands to evaluate for MS

CLINICAL ISSUES

  • Presentation

    • Most common signs/symptoms

      - Unilateral or bilateral ON
              - Varying degrees of vision loss + eye pain worsened with eye movement
              - Most common clinical MOGAD manifestation at onset
              - Visual loss typically central and severe (more severe in MOGAD than MS, similar in severity to NMOSD
              - Opticospinal phenotype increases in frequency as children get older
      - ADEM-like presentation with altered mental status, focal neurologic deficits
              - Up to 68% of cases at initial presentation
              - Some MOGAD patients have clinical and MR features of ADEM but not encephalopathy
              - Recurrence of ADEM features after recovery suggests MOGAD
      - TM
              - Limb weakness, sensory loss, and bowel, bladder, or sexual dysfunction
      - Cerebral cortical encephalitis
              - Headache, seizures, stroke-like episodes, and focal neurologic deficits
              - Seizures more common than with NMOSD and MS
      
    • Other signs/symptoms

      - Rare: Progressive clinical decline with leukodystrophy-like MR pattern
      
    • Clinical profile

      - Most common pediatric clinical phenotype is ADEM-like encephalopathy, ON (or both), followed by TM
      
  • Demographics

    • Age

      - Predilection for children but can affect any age
              - Median age of MOGAD onset: 20-30 years
              - Children: ≈ 50% of MOGAD cases
      
    • Sex

      - M = F
      
    • Epidemiology

      - Incidence and prevalence largely unknown
              - European studies suggest incidence 1.6-3.4 per 1,000,000 person-years
      
  • Natural History & Prognosis

    • Infectious prodrome precedes initial symptom onset ≤ 60% of patients
    • Monophasic or relapsing course (≈ 50/50) - ON is most common relapse manifestation (followed by TM)
    • Attacks develop over days, plateau with variable recovery over weeks to months
    • Most T2 lesions resolve completely over months to few years - Useful discriminator from MS and AQP4-IgG NMOSD, in which majority have residual T2-hyperintense lesions
    • MOG-associated ON generally responds well to steroid administration - Optic nerve edema and enlargement may resolve with residual T2 hyperintensity and optic nerve atrophy
    • Visual outcomes after MOG-associated ON better than NMOSD
    • Long-term disability rates lower than with NMOSD or MS - MOGAD not associated with primary or secondary progressive course
    • Low mortality
  • Treatment

    • Glucocorticoid therapy 1st line

DIAGNOSTIC CHECKLIST

  • Consider

    • Simultaneous bilateral ON involving anterior optic pathway with associated optic disc edema strongly implies MOGAD
  • Image Interpretation Pearls

    • Evaluate optic apparatus carefully on brain imaging to identify concurrent ON

2d7cd594-5de1-4c79-a3d7-f6a7c5e45a2a

References

Selected References

  1. Banwell B et al: Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 22(3):268-82, 2023
  2. Gilani A et al: Childhood small-vessel primary angiitis of the central nervous system: overlap with MOG-associated disease. Pediatr Dev Pathol. 26(1):18-29, 2023
  3. Bells S et al: Patterns of white and gray structural abnormality associated with paediatric demyelinating disorders. Neuroimage Clin. 34:103001, 2022
  4. Lasrado A et al: Optic chiasm, optic tract and deep white demyelination: an unusual distribution of myelin oligodendrocyte glycoprotein-associated demyelination (MOGAD), case report and review of literature. BMJ Case Rep. 15(7):e249398, 2022
  5. Lin S et al: Myelin oligodendrocyte glycoprotein antibody-associated aseptic meningitis without neurological parenchymal lesions: a novel phenotype. Mult Scler Relat Disord. 68:104126, 2022
  6. Cobo-Calvo A et al: Clinical features and risk of relapse in children and adults with myelin oligodendrocyte glycoprotein antibody-associated disease. Ann Neurol. 89(1):30-41, 2021
  7. Gadde JA et al: Rate of leptomeningeal enhancement in pediatric myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis. J Child Neurol. 36(11):1042-6, 2021
  8. Li Y et al: Clinical and radiological characteristics of children and adults with first-attack myelin oligodendrocyte glycoprotein antibody disease and analysis of risk factors for predicting the severity at disease onset in central China. Front Immunol. 12:752557, 2021
  9. Lopez Chiriboga S et al: Myelitis and other autoimmune myelopathies. Continuum (Minneap Minn). 27(1):62-92, 2021
  10. Shahriari M et al: MOGAD: How it differs from and resembles other neuroinflammatory disorders. AJR Am J Roentgenol. 216(4):1031-9, 2021
  11. Ambrosius W et al: Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, diagnosis and management. Int J Mol Sci. 22(1):100, 2020
  12. Armangue T et al: Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study. Lancet Neurol. 19(3):234-46, 2020
  13. Banks SA et al: Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS. J Neurol Neurosurg Psychiatry. jnnp-2020-325121, 2020
  14. Chen JJ et al: Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis. Curr Opin Neurol. 33(1):47-54, 2020
  15. Höftberger R et al: The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody. Acta Neuropathol. 139(5):875-92, 2020
  16. O'Connell K et al: Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK. J Neurol Neurosurg Psychiatry. 91(10):1126-8, 2020
  17. Takai Y et al: Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. Brain. 143(5):1431-46, 2020
  18. Waters P et al: Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes. JAMA Neurol. 77(1):82-93, 2020
  19. Dubey D et al: Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol. 76(3):301-9, 2019
  20. Mariano R et al: Comparison of clinical outcomes of transverse myelitis among adults with myelin oligodendrocyte glycoprotein antibody vs aquaporin-4 antibody disease. JAMA Netw Open. 2(10):e1912732, 2019
  21. Salama S et al: MOG antibody-associated encephalomyelitis/encephalitis. Mult Scler. 25(11):1427-33, 2019
  22. Cobo-Calvo A et al: Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study. Neurology. 90(21):e1858-69, 2018
  23. Hamid SHM et al: Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease. JAMA Neurol. 75(1):65-71, 2018
  24. López-Chiriboga AS et al: Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders. JAMA Neurol. 75(11):1355-63, 2018
  25. Ramanathan S et al: Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry. 89(2):127-37, 2018
  26. Fujimori J et al: Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies. J Neurol Neurosurg Psychiatry. 88(6):534-6, 2017
  27. Hennes EM et al: Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology. 89(9):900-8, 2017
  28. Jurynczyk M et al: Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 140(12):3128-38, 2017
  29. Ogawa R et al: MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy. Neurol Neuroimmunol Neuroinflamm. 4(2):e322, 2017
  30. Ramanathan S et al: Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler. 22(4):470-82, 2016
  31. Krupp LB et al: International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 19(10):1261-7, 2013
  32. Wolf VL et al: Pediatric acute transverse myelitis overview and differential diagnosis. J Child Neurol. 27(11):1426-36, 2012

Images

Selected Images

Axial FLAIR MR in a 10-year-old with acute myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) shows characteristic thalamic , basal ganglia , hypothalamic , and insular cortex  hyperintense lesions. The hypothalamic lesions are relatively subtle but correlated clinically with lethargy and hypothalamic symptoms and signs. Axial FLAIR MR in a 10-year-old with acute myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) shows characteristic thalamic , basal ganglia , hypothalamic , and insular cortex hyperintense lesions. The hypothalamic lesions are relatively subtle but correlated clinically with lethargy and hypothalamic symptoms and signs.

Axial FLAIR MR in a 10-year-old with acute myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) shows characteristic thalamic , basal ganglia , hypothalamic , and insular cortex  hyperintense lesions. The hypothalamic lesions are relatively subtle but correlated clinically with lethargy and hypothalamic symptoms and signs. Axial FLAIR MR in a 10-year-old with acute myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) shows characteristic thalamic , basal ganglia , hypothalamic , and insular cortex hyperintense lesions. The hypothalamic lesions are relatively subtle but correlated clinically with lethargy and hypothalamic symptoms and signs.

Axial FLAIR MR in the same patient additionally reveals brainstem/cerebellar peduncle , deep cerebellar white matter  , and cerebellar hemisphere  lesions. Axial FLAIR MR in the same patient additionally reveals brainstem/cerebellar peduncle , deep cerebellar white matter , and cerebellar hemisphere lesions.

Axial T1 C+ FS MR in the same patient shows patchy enhancement of the thalamic, basal ganglia, and hypothalamic lesions. In this patient, the hypothalamic lesions are conspicuous on contrast imaging but subtle on noncontrast FLAIR MR. Axial T1 C+ FS MR in the same patient shows patchy enhancement of the thalamic, basal ganglia, and hypothalamic lesions. In this patient, the hypothalamic lesions are conspicuous on contrast imaging but subtle on noncontrast FLAIR MR.

Axial T1 C+ FS MR in the same patient 3 months prior reveals avid contrast enhancement of the left optic nerve (anterior segment) . Laboratory assessment at that time confirmed MOG antibodies, but brain imaging was normal (not shown). Axial T1 C+ FS MR in the same patient 3 months prior reveals avid contrast enhancement of the left optic nerve (anterior segment) . Laboratory assessment at that time confirmed MOG antibodies, but brain imaging was normal (not shown).

Axial FLAIR MR in a 4-year-old with florid optic neuritis and encephalopathy with positive anti-MOG antibody titer reveals abnormal hyperintensity and swelling within the bilateral basal ganglia , insular cortex , perventricular white matter, and posterior thalami. Axial FLAIR MR in a 4-year-old with florid optic neuritis and encephalopathy with positive anti-MOG antibody titer reveals abnormal hyperintensity and swelling within the bilateral basal ganglia , insular cortex , perventricular white matter, and posterior thalami.

Axial T1 C+ FS MR in the same patient reveals minimal, if any, enhancement within the same abnormal brain regions. Axial T1 C+ FS MR in the same patient reveals minimal, if any, enhancement within the same abnormal brain regions.

Axial FLAIR MR in a 4-year-old with severe onset of encephalopathy with positive MOG antibody titer depicts several areas of abnormal cortical hyperintensity and edema  as well as subcortical white matter signal abnormalities. Axial FLAIR MR in a 4-year-old with severe onset of encephalopathy with positive MOG antibody titer depicts several areas of abnormal cortical hyperintensity and edema as well as subcortical white matter signal abnormalities.

Axial T1 C+ FS MR in the same patient reveals subtle leptomeningeal enhancement  over the right parietal lobe. This constellation of findings represents cerebral cortical encephalitis, a finding unique to MOGAD and potentially predisposing to seizures. Axial T1 C+ FS MR in the same patient reveals subtle leptomeningeal enhancement over the right parietal lobe. This constellation of findings represents cerebral cortical encephalitis, a finding unique to MOGAD and potentially predisposing to seizures.

Axial FLAIR MR in a 5-year-old patient with florid encephalopathy and emesis reveals multifocal T2-hyperintense lesions predominantly localizing to the brainstem and posterior fossa. Lesions are noted in the middle cerebellar peduncles, deep cerebellar white matter, and dorsal brainstem  near the facial colliculus (area postrema, explaining vomiting). Axial FLAIR MR in a 5-year-old patient with florid encephalopathy and emesis reveals multifocal T2-hyperintense lesions predominantly localizing to the brainstem and posterior fossa. Lesions are noted in the middle cerebellar peduncles, deep cerebellar white matter, and dorsal brainstem near the facial colliculus (area postrema, explaining vomiting).

Axial T1 C+ FS MR in the same patient reveals patchy partial ring and nodular enhancement in these abnormal areas. Axial T1 C+ FS MR in the same patient reveals patchy partial ring and nodular enhancement in these abnormal areas.

Additional Images

Axial FLAIR MR in a 7-year-old patient with MOGAD reveals subcortical white matter   and deep nuclear gray matter  involvement. This is a fairly typical appearance for MOGAD MR abnormalities. Axial FLAIR MR in a 7-year-old patient with MOGAD reveals subcortical white matter and deep nuclear gray matter involvement. This is a fairly typical appearance for MOGAD MR abnormalities.

Axial FLAIR MR in the same patient confirms patchy brainstem signal abnormality  as well. This patient also presented with severe transverse myelopathy with longitudinally extensive transverse myelitis (LETM) pattern on spine MR (not shown). Axial FLAIR MR in the same patient confirms patchy brainstem signal abnormality as well. This patient also presented with severe transverse myelopathy with longitudinally extensive transverse myelitis (LETM) pattern on spine MR (not shown).

Coronal T2 MR through the frontal lobes of a pediatric patient with encephalopathy, optic neuritis, and confirmed MOGAD reveals abnormal hyperintensity within the left basal ganglia  as well as mild hyperintensity in the left cisternal optic nerve . Coronal T2 MR through the frontal lobes of a pediatric patient with encephalopathy, optic neuritis, and confirmed MOGAD reveals abnormal hyperintensity within the left basal ganglia as well as mild hyperintensity in the left cisternal optic nerve .

Coronal T1 C+ FS MR in the same patient shows no enhancement in the slightly hypointense basal ganglia lesion   , but avid enhancement of both cisternal optic nerves  (bilateral anterior segment optic neuritis). Contrast is essential for assessing the optic nerves for signs of neuritis. Coronal T1 C+ FS MR in the same patient shows no enhancement in the slightly hypointense basal ganglia lesion , but avid enhancement of both cisternal optic nerves (bilateral anterior segment optic neuritis). Contrast is essential for assessing the optic nerves for signs of neuritis.